Backed by advancing endoscopic care and growing demand for non-surgical obstruction management, the gastrointestinal stent market was valued at USD 586.23 million in the base year 2025 and is projected to reach USD 618.54 million in 2026 and USD 958.81 million by 2034, registering a CAGR of 5.62% during the forecast period 2026–2034. Prominent players include Merit Medical Systems, Inc., ELLA-CS, s.r.o., Taewoong Medical Co., Ltd., Micro-Tech (Nanjing) Co., Ltd., ENDO-FLEX GmbH, and M.I.Tech Co., Ltd.

Regional Outlook: North America Leads, Asia Pacific Accelerates

North America dominated the gastrointestinal stent market in 2025 with approximately 41.10% share, supported by advanced healthcare infrastructure and high procedure volume. United States Cancer Statistics estimated 147,931 newly diagnosed colorectal cancer patients in 2022, and favorable reimbursement and the presence of key players improve access to therapy.

Asia Pacific is projected to grow at the fastest CAGR. According to the National Library of Medicine, Asia accounted for 50.2% of global colorectal cancers in 2022, while developing healthcare infrastructure in India and China lifts demand. India committed USD 11.50 billion to healthcare in its 2025-2026 union budget, a 9.78% increase. Europe held the second-largest share on advanced infrastructure and rising pancreatic cancer incidence, with stable demand in Germany, France, and the UK. Latin America and the Middle East & Africa are growing steadily, with Brazil and South Africa deepening their use of endoscopic procedures.

Europe also benefits from growth in early diagnostic initiatives and the introduction of novel stent technology. Rising government initiatives and expanding endoscopic treatment facilities support Asia Pacific, while the rise of private healthcare establishments and adoption of minimally invasive technology contribute to growth in emerging markets. In the US, colorectal cancer mortality was recorded at 53,779 in 2023.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/gastrointestinal-stent-market

Clinical Use Cases in the Gastrointestinal Stent Market

Colorectal cancer is the fastest-growing application, driven by the rising global burden of malignancies and preference for minimally invasive palliative treatments. Stents are increasingly used to relieve obstruction and avoid emergency surgeries, especially in advanced-stage patients, a use case directly relevant to the colonic stent product category.

Metal stents are used to manage malignant obstructions in the gastrointestinal tract. In March 2026, Merit Medical Systems launched the Resilience Through-the-Scope (TTS) Esophageal Stent for esophageal fistulas and strictures caused by malignant tumors, illustrating continued product innovation in the esophageal stent category.

Major applications include gastrointestinal cancer, biliary disease, colorectal cancer, and stomach cancer. The rising trend toward minimally invasive techniques for endoscopic procedures has contributed to growing use of metallic stents, and hospitals and ambulatory surgery centers remain the main care settings where stenting is performed.

Technology Innovation and Design Trade-Offs

Nitinol-based self-expandable metal stents are gaining adoption for superior flexibility, shape memory, and placement accuracy. Drug-eluting stents release medicines directly at the tumor site to control tumor growth and restenosis, while anti-migration stents and hybrid stents improve stability and lumen patency. Advanced coatings help avoid infections, biofilms, and blockages, and AI-enabled, image-based insertion is improving outcomes.

Design choices involve trade-offs. Covered stents offer high tumor ingrowth prevention and longer patency but carry higher migration risk and cost, whereas uncovered stents provide lower migration risk and better anchoring but face tumor ingrowth risk.

Covered stents suit malignant strictures and palliative care and deliver better obstruction control, while uncovered stents are used for biliary obstruction and long-term placement. Artificial intelligence enhances procedural precision through image-guided placement and supports predictive, real-time decision-making.

Competitive Landscape and Opportunities

The gastrointestinal stent market is moderately fragmented, with global medical device manufacturers and dedicated firms present in each product category. Competition depends on product quality, performance, and pricing, and companies are targeting innovation and minimally invasive treatment options. Other participants include Boston Scientific Corporation, Olympus Corporation, Cook Medical LLC, Medtronic plc, HOBBS MEDICAL, INC., and Becton, Dickinson and Company.

Development of biodegradable designs and expansion into emerging markets are creating long-term opportunities as healthcare investment and specialty care centers grow in developing nations.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market